US EditionPublished • loading... • Updated
APCI Calls for Passage of the Pharmacists Fight Back Act, Delivering Major Savings and Protections for Patients and Taxpayers
The Pharmacists Fight Back Act includes bipartisan support and mandates rebate sharing at the counter to reduce federal healthcare spending and patient costs.
- Dec. 11, 2025, Rep. Jake Auchincloss reintroduced the Pharmacists Fight Back Act, a two-bill package, at a Capitol Hill press conference as APCI called on Congress to pass it.
- Framed as consumer-focused reform, the bills seek to lower prescription drug costs and end PBM practices which APCI calls exploitative to protect patient access, with the original 2024 bill earning 55 bipartisan cosponsors.
- Requiring direct-to-patient rebate sharing, the bills mandate PBMs share manufacturer rebates at the pharmacy counter, establish market-based index pricing, and ban steering to PBM-owned pharmacies.
- The bills include robust oversight and penalties to prevent PBMs from sidestepping protections, safeguarding taxpayer investments in Medicare, Medicaid and the Federal Employee Health Benefits Program .
- Supporters can learn more or contact their representatives via bit.ly/pharmacists-fight-back, while APCI provided detailed analysis to Congressional offices during policy development.
Insights by Ground AI
18 Articles
18 Articles
APCI Calls for Passage of the Pharmacists Fight Back Act, Delivering Major Savings and Protections for Patients and Taxpayers
BESSEMER, Ala., Dec. 11, 2025 /PRNewswire/ -- American Pharmacy Cooperative, Inc. (APCI) today called on Congress to pass the reintroduced Pharmacists Fight Back Act, two coordinated pieces of federal legislation designed to reform pharmacy benefit manager (PBM) practices.
Coverage Details
Total News Sources18
Leaning Left1Leaning Right1Center8Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
C 80%
Factuality
To view factuality data please Upgrade to Premium
